As of 2024-07-27, the Relative Valuation of Blueprint Medicines Corp (BPMC) is (106.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 112.19 USD, the upside of Blueprint Medicines Corp based on Relative Valuation is -194.8%.
The range of the Relative Valuation is (97.04) - (132.77) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.5x - 29.1x | 22.4x |
| Forward P/E multiples | 21.1x - 28.8x | 23.8x |
| Fair Price | (97.04) - (132.77) | (106.34) |
| Upside | -186.5% - -218.3% | -194.8% |
| Date | P/E |
| 2024-07-26 | -24.37 |
| 2024-07-25 | -24.70 |
| 2024-07-24 | -24.98 |
| 2024-07-23 | -25.40 |
| 2024-07-22 | -25.37 |
| 2024-07-19 | -24.97 |
| 2024-07-18 | -24.65 |
| 2024-07-17 | -24.84 |
| 2024-07-16 | -26.17 |
| 2024-07-15 | -25.96 |
| 2024-07-12 | -25.58 |
| 2024-07-11 | -25.59 |
| 2024-07-10 | -25.19 |
| 2024-07-09 | -25.03 |
| 2024-07-08 | -25.27 |
| 2024-07-05 | -24.26 |
| 2024-07-03 | -23.68 |
| 2024-07-02 | -23.97 |
| 2024-07-01 | -23.72 |
| 2024-06-28 | -23.41 |
| 2024-06-27 | -23.57 |
| 2024-06-26 | -22.57 |
| 2024-06-25 | -23.14 |
| 2024-06-24 | -23.05 |
| 2024-06-21 | -22.64 |
| 2024-06-20 | -22.85 |
| 2024-06-18 | -23.18 |
| 2024-06-17 | -22.56 |
| 2024-06-14 | -22.93 |
| 2024-06-13 | -23.11 |
| 2024-06-12 | -23.06 |
| 2024-06-11 | -22.89 |
| 2024-06-10 | -22.60 |
| 2024-06-07 | -22.45 |
| 2024-06-06 | -22.68 |
| 2024-06-05 | -22.99 |
| 2024-06-04 | -22.13 |
| 2024-06-03 | -22.77 |
| 2024-05-31 | -22.93 |
| 2024-05-30 | -23.10 |
| 2024-05-29 | -21.85 |
| 2024-05-28 | -22.23 |
| 2024-05-24 | -22.33 |
| 2024-05-23 | -22.24 |
| 2024-05-22 | -22.31 |
| 2024-05-21 | -22.51 |
| 2024-05-20 | -22.65 |
| 2024-05-17 | -22.80 |
| 2024-05-16 | -23.16 |
| 2024-05-15 | -23.20 |